BICLUSTER_ID : UPREG-60
PATHOGENS /3/ : escherichia coli,helicobacter pylori,ehrlichia chaffeensis
TARGETS /21/ : CD44, CCL2, TNFRSF1B, HCK, VCAM1, CYP1B1, AMPD3, CCL5, SAT1, SELP, ABCC1, JAK2, WARS, IL6, PTGS2, ICAM1, SELE, IL1R1, TLR2, TNF, PLAUR
Gene SetLeading Edge Genes
NETPATH B CELL RECEPTOR PATHWAY UPBIRC3, EREG, CD69, CCL2, CD44, HCK, CYP1B1, TRAF1, LCP2, TNFAIP3, ICAM1, CCL5, MYC, MYD88, TNF
NETPATH IL 2 PATHWAY UPPFKFB3, TNFRSF1B, PMAIP1, IER3, STK17B, KLF6, WARS, CD69, IL18R1, GADD45G, SRC, PTP4A1, FAS, IL6, PBEF1, ICAM1, IRF1, IL1R1, UPP1, MYC, PLAUR, TNF
NETPATH IL 4 PATHWAY DOWNPDGFB, GADD45B, CCL2, GBP2, NFKBIA, GEM, IL6, PTGS2, ICAM1, IRF1, CXCL2, TLR2, TNF
NETPATH IL 1 PATHWAY UPBIRC3, CXCL1, WARS, CCL2, NFKBIE, CXCL5, NFKBIA, CCL7, IL6, PTGS2, AMPD3, PBEF1, ICAM1, CXCL2
NETPATH IL 5 PATHWAY UPNFKBIB, IRF2, PLSCR1, NFKB2, NFKBIE, CCL2, CD44, RELB, IER3, MYD88, CASP4, BIRC3, SELP, REL, TBK1, ICAM1, SELE, UPP1
NETPATH IL 4 PATHWAY UPSTK17B, REL, IBRDC3, CCL2, CEBPB, VCAM1, CYP1B1, IL6, IL1RN, SELE, RIPK2, UPP1, MYC
NCI IL23PATHWAYNFKBIA, IL6, CXCL1, JAK2, CCL2, TNF
SA MMP CYTOKINE CONNECTIONCSF1, CD44, SELL, TNFRSF1B, TNF
NCI IL6 7PATHWAYJAK2, CEBPD, TIMP1, JUNB, CEBPB, HCK, LMO4, IL6, IRF1, MYC
NETPATH IL 6 PATHWAY UPGADD45B, CXCL1, ABCC1, JUNB, CEBPB, CD44, MAP3K8, MAFF, IRF1, TNF
NETPATH IL 7 PATHWAY UPCXCL5, FAS, CXCL1, CCL5, CD44, CXCL2, MYC
GERY CEBP TARGETSGADD45B, CXCL1, EREG, JUNB, GADD45G, RGS16, ATF3, SAT1, PLAUR, BTG2
ST TUMOR NECROSIS FACTOR PATHWAYNFKBIA, BIRC3, TNFAIP3, NFKB2, NFKBIE, BIRC2, TNFRSF1B, TNF
NCI IL12 2PATHWAYGADD45B, JAK2, NFKB2, IL18R1, GADD45G, RIPK2, RELB, IL1R1
NETPATH IL 3 PATHWAY UPCCL7, CSF1, CCL2, MYC, TNF
NETPATH IL 9 PATHWAY UPCCL7, CCL2, JUNB, SELL, MYC
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
BIOCARTA NFKB PATHWAY
MAHAJAN RESPONSE TO IL1A UP
WEINMANN ADAPTATION TO HYPOXIA DN
KEGG GRAFT VERSUS HOST DISEASE
VARELA ZMPSTE24 TARGETS UP
NCI TNFPATHWAY
REACTOME PEPTIDE LIGAND BINDING RECEPTORS
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
RASHI RESPONSE TO IONIZING RADIATION 2
RADAEVA RESPONSE TO IFNA1 UP
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
AMIT EGF RESPONSE 40 HELA
MUNSHI MULTIPLE MYELOMA UP
AMIT EGF RESPONSE 480 HELA
JEON SMAD6 TARGETS UP
MITSIADES RESPONSE TO APLIDIN UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
HASINA NOL7 TARGETS UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
LENAOUR DENDRITIC CELL MATURATION DN
HINATA NFKB TARGETS KERATINOCYTE UP
RUTELLA RESPONSE TO CSF2RB AND IL4 UP
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
MARKEY RB1 ACUTE LOF UP
COULOUARN TEMPORAL TGFB1 SIGNATURE UP
HUANG FOXA2 TARGETS UP
POOLA INVASIVE BREAST CANCER UP
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
AMIT EGF RESPONSE 120 HELA
NCI CHEMOKINE RECEPTORS BIND CHEMOKINES
DANG REGULATED BY MYC DN
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP
MCLACHLAN DENTAL CARIES UP
GAJATE RESPONSE TO TRABECTEDIN UP
PODAR RESPONSE TO ADAPHOSTIN UP
LEE LIVER CANCER E2F1 UP
KERLEY RESPONSE TO CISPLATIN UP
HELLER SILENCED BY METHYLATION UP
LAU APOPTOSIS CDKN2A UP
ZHOU INFLAMMATORY RESPONSE LPS UP
SMID BREAST CANCER LUMINAL B DN
WONG ENDMETRIUM CANCER UP
NETPATH TGFBETA RECEPTOR PATHWAY DOWN
VANTVEER BREAST CANCER ESR1 DN
CORUM REL-MAP3K8-RELA-TNIP2-PAPOLA COMPLEX
REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
NCI P53DOWNSTREAMPATHWAY
CORUM IKBEPSILON-RELA-CREL COMPLEX
CHASSOT SKIN WOUND
TIAN TNF SIGNALING VIA NFKB
HUMMEL BURKITTS LYMPHOMA DN
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
KEGG APOPTOSIS
CORUM NFKB1-NFKB2-REL-RELA-RELB COMPLEX
HINATA NFKB TARGETS FIBROBLAST UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
MISSIAGLIA REGULATED BY METHYLATION UP
NCI ATF2 PATHWAY
GEORGANTAS HSC MARKERS
SESTO RESPONSE TO UV C1
CROONQUIST STROMAL STIMULATION UP
CHIARADONNA NEOPLASTIC TRANSFORMATION CDC25 UP
ZHANG RESPONSE TO CANTHARIDIN UP
DACOSTA ERCC3 ALLELE XPCS VS TTD UP
HORIUCHI WTAP TARGETS UP
NCI CMYB PATHWAY
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
BIOCARTA SODD PATHWAY
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
KEGG JAK STAT SIGNALING PATHWAY
TSAI DNAJB4 TARGETS UP
SCHAVOLT TARGETS OF TP53 AND TP63
MORI PRE BI LYMPHOCYTE DN
DER IFN BETA RESPONSE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLACK UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
NUNODA RESPONSE TO DASATINIB IMATINIB UP
NCI FASL CD95L SIGNALING
AMIT EGF RESPONSE 20 HELA
GALI TP53 TARGETS APOPTOTIC UP
MUELLER METHYLATED IN GLIOBLASTOMA
BASSO CD40 SIGNALING UP
NAGASHIMA NRG1 SIGNALING UP
MARZEC IL2 SIGNALING UP
BIOCARTA BLYMPHOCYTE PATHWAY
ZERBINI RESPONSE TO SULINDAC UP
CROMER TUMORIGENESIS UP
FRIDMAN SENESCENCE UP
WU HBX TARGETS 2 DN
MAHADEVAN RESPONSE TO MP470 UP
FERRARI RESPONSE TO FENRETINIDE UP
BIOCARTA TID PATHWAY
AMUNDSON GAMMA RADIATION RESISTANCE
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
BIOCARTA CTL PATHWAY
KEGG LEISHMANIA INFECTION
WU HBX TARGETS 1 UP
CHEN HOXA5 TARGETS 9HR UP
KANNAN TP53 TARGETS UP
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
PARK TRETINOIN RESPONSE AND PML RARA FUSION
ENGELMANN CANCER PROGENITORS UP
FOSTER INFLAMMATORY RESPONSE LPS UP
SENESE HDAC1 TARGETS UP
LIU TARGETS OF VMYB VS CMYB DN
INGA TP53 TARGETS
KIM WT1 TARGETS UP
KEGG CYTOSOLIC DNA SENSING PATHWAY
BIOCARTA GRANULOCYTES PATHWAY
HESS TARGETS OF HOXA9 AND MEIS1 DN
ELVIDGE HYPOXIA BY DMOG UP
BIOCARTA TOLL PATHWAY
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
VERRECCHIA EARLY RESPONSE TO TGFB1
RUTELLA RESPONSE TO HGF UP
PRAMOONJAGO SOX4 TARGETS UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
ELVIDGE HIF1A TARGETS DN
LENAOUR DENDRITIC CELL MATURATION UP
ZHU CMV 24 HR UP
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
CHEN LVAD SUPPORT OF FAILING HEART UP
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION A
ELVIDGE HYPOXIA UP
NETPATH TGFBETA RECEPTOR PATHWAY UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
BROWNE INTERFERON RESPONSIVE GENES
REACTOME SIGNALING IN IMMUNE SYSTEM
BIOCARTA LAIR PATHWAY
FRIDMAN IMMORTALIZATION DN
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
DAZARD UV RESPONSE CLUSTER G3
XU HGF TARGETS INDUCED BY AKT1 48HR UP
OSADA ASCL1 TARGETS DN
VART KSHV INFECTION ANGIOGENIC MARKERS UP
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER DN
TSAI RESPONSE TO IONIZING RADIATION
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
NCI NFAT TFPATHWAY
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
BIOCARTA ERYTH PATHWAY
HELLEBREKERS SILENCED DURING TUMOR ANGIOGENESIS
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
WINTER HYPOXIA METAGENE
BROWNE HCMV INFECTION 8HR UP
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX CHUK KPNA3 NFKB2 NFKBIB REL IKBKG NFKB1 NFKBIE RELB NFKBIA RELA TNIP2
FOSTER INFLAMMATORY RESPONSE LPS DN
TAVOR CEBPA TARGETS UP
GAURNIER PSMD4 TARGETS
BIOCARTA HIVNEF PATHWAY
NETPATH TNF ALPHA PATHWAY UP
MARKEY RB1 CHRONIC LOF DN
NCI AMB2 NEUTROPHILS PATHWAY
GESERICK TERT TARGETS DN
AMIT SERUM RESPONSE 120 MCF10A
BROWNE HCMV INFECTION 2HR UP
SESTO RESPONSE TO UV C3
REACTOME DEATH RECEPTOR SIGNALLING
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
ZHOU INFLAMMATORY RESPONSE FIMA UP
ZHU CMV ALL UP
OKUMURA INFLAMMATORY RESPONSE LPS
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
AMIT DELAYED EARLY GENES
AMIT EGF RESPONSE 60 MCF10A
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
NOJIMA SFRP2 TARGETS UP
CHEN HOXA5 TARGETS 6HR UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
AUJLA IL22 AND IL17A SIGNALING
LEE LIVER CANCER MYC TGFA UP
HALMOS CEBPA TARGETS UP
NCI A4B1 PAXINDEP PATHWAY
WALLACE PROSTATE CANCER RACE UP
SAGIV CD24 TARGETS DN
KEGG MAPK SIGNALING PATHWAY
WIELAND UP BY HBV INFECTION
ONDER CDH1 SIGNALING VIA CTNNB1
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
MAHADEVAN RESPONSE TO MP470 DN
UROSEVIC RESPONSE TO IMIQUIMOD
HARRIS HYPOXIA
NETPATH KIT RECEPTOR PATHWAY UP
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
KAN RESPONSE TO ARSENIC TRIOXIDE
NCI IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL
SOUCEK MYC TARGETS
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
SCIAN INVERSED TARGETS OF TP53 AND TP73 DN
BILD HRAS ONCOGENIC SIGNATURE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
DER IFN ALPHA RESPONSE UP
AMIT EGF RESPONSE 60 HELA
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
BERENJENO TRANSFORMED BY RHOA FOREVER DN
BIOCARTA GSK3 PATHWAY
DAZARD UV RESPONSE CLUSTER G2
NCI CD40 PATHWAY
MCLACHLAN DENTAL CARIES DN
GUENTHER GROWTH SPHERICAL VS ADHERENT DN
AMIT SERUM RESPONSE 40 MCF10A
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
WONG ENDOMETRIAL CANCER LATE
ZHU CMV 8 HR UP
BIERIE INFLAMMATORY RESPONSE TGFB1
BIOCARTA INFLAM PATHWAY
SANA TNF SIGNALING UP
NCI IL27PATHWAY
SENESE HDAC1 AND HDAC2 TARGETS UP
XU HGF TARGETS INDUCED BY AKT1 6HR
EBAUER TARGETS OF PAX3 FOXO1 FUSION UP
ONDER CDH1 TARGETS 2 DN
MANALO HYPOXIA UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
SENESE HDAC3 TARGETS UP
KEGG CHEMOKINE SIGNALING PATHWAY
XU HGF SIGNALING NOT VIA AKT1 6HR
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
BIOCARTA KERATINOCYTE PATHWAY
XU HGF SIGNALING NOT VIA AKT1 48HR UP
DASU IL6 SIGNALING UP
NETPATH T CELL RECEPTOR PATHWAY UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
GOUYER TATI TARGETS UP
ZUCCHI METASTASIS DN
NUNODA RESPONSE TO DASATINIB IMATINIB DN
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
helicobacter pylori kx1 mgepehrlichia chaffeensis arkansaescherichia coliGeneSet Name
0.01192 0.01457 0.00228NETPATH_B_CELL_RECEPTOR_PATHWAY_UP
0.02575 0.00029 0.00000NETPATH_IL_2_PATHWAY_UP
0.00002 0.00001 0.00000NETPATH_IL_4_PATHWAY_DOWN
0.00000 0.00744 0.00000NETPATH_IL_1_PATHWAY_UP
0.00021 0.00007 0.00001NETPATH_IL_5_PATHWAY_UP
0.00423 0.00011 0.00129NETPATH_IL_4_PATHWAY_UP
0.00589 0.00000 0.00000NCI_IL23PATHWAY
0.01005 0.00037 0.00133SA_MMP_CYTOKINE_CONNECTION
0.04616 0.00000 0.00785NCI_IL6_7PATHWAY
0.00236 0.00003 0.00000NETPATH_IL_6_PATHWAY_UP
0.00294 0.00034 0.00000NETPATH_IL_7_PATHWAY_UP
0.00133 0.01308 0.01389GERY_CEBP_TARGETS
0.00032 0.00584 0.00026ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.05996 0.00000 0.00000NCI_IL12_2PATHWAY
0.03326 0.00000 0.00000NETPATH_IL_3_PATHWAY_UP
0.00013 0.00097 0.00028NETPATH_IL_9_PATHWAY_UP
0.03509 0.00021 0.00000GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00155 0.06659 0.00000BIOCARTA_NFKB_PATHWAY
0.00517 0.01198 0.00000MAHAJAN_RESPONSE_TO_IL1A_UP
0.07109 0.01089 0.00000WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.02385 0.00000 0.00002KEGG_GRAFT_VERSUS_HOST_DISEASE
0.00006 0.05834 0.01038VARELA_ZMPSTE24_TARGETS_UP
0.00024 0.16521 0.00010NCI_TNFPATHWAY
0.09639 0.00094 0.00015REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.00000 0.00007 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00078 0.17481 0.00000BIOCARTA_IL1R_PATHWAY
0.00000 0.00307 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.08041 0.00000 0.00000RADAEVA_RESPONSE_TO_IFNA1_UP
0.00132 0.03933 0.00127LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.00125 0.03874 0.00000AMIT_EGF_RESPONSE_40_HELA
0.15913 0.02605 0.03400MUNSHI_MULTIPLE_MYELOMA_UP
0.01233 0.12490 0.01590AMIT_EGF_RESPONSE_480_HELA
0.00006 0.00046 0.00031JEON_SMAD6_TARGETS_UP
0.00011 0.09988 0.02480MITSIADES_RESPONSE_TO_APLIDIN_UP
0.00000 0.01384 0.00000THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.03175 0.18351 0.05915HASINA_NOL7_TARGETS_UP
0.10179 0.00081 0.00220TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.11960 0.00000 0.02437LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.00002 0.00055 0.00000HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.11690 0.08512 0.00016RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
0.10157 0.03945 0.00331KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.07713 0.00000 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.02584 0.11433 0.01809COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.05378 0.16421 0.00285HUANG_FOXA2_TARGETS_UP
0.13876 0.00000 0.03522POOLA_INVASIVE_BREAST_CANCER_UP
0.04004 0.01711 0.10906RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.00018 0.00000 0.00000REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00003 0.07404 0.00046AMIT_EGF_RESPONSE_120_HELA
0.05605 0.06101 0.04474NCI_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.13597 0.00130 0.02480DANG_REGULATED_BY_MYC_DN
0.13610 0.00549 0.00949FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.00018 0.00000 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.09307 0.02606 0.00098GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.00015 0.00428 0.01026PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.17072 0.00000 0.00843LEE_LIVER_CANCER_E2F1_UP
0.02159 0.06718 0.11052KERLEY_RESPONSE_TO_CISPLATIN_UP
0.02029 0.00000 0.00002HELLER_SILENCED_BY_METHYLATION_UP
0.00207 0.06604 0.10195LAU_APOPTOSIS_CDKN2A_UP
0.00307 0.00269 0.00000ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.17326 0.00000 0.00006SMID_BREAST_CANCER_LUMINAL_B_DN
0.19450 0.02264 0.12623WONG_ENDMETRIUM_CANCER_UP
0.14159 0.05857 0.06355NETPATH_TGFBETA_RECEPTOR_PATHWAY_DOWN
0.12569 0.00020 0.00141VANTVEER_BREAST_CANCER_ESR1_DN
0.12111 0.10047 0.01415CORUM_REL-MAP3K8-RELA-TNIP2-PAPOLA_COMPLEX
0.07216 0.00000 0.00800REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.00063 0.00000 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.01130 0.00000 0.00002BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.03315 0.07476 0.00831NCI_P53DOWNSTREAMPATHWAY
0.10711 0.19549 0.08427CORUM_IKBEPSILON-RELA-CREL_COMPLEX
0.01494 0.15171 0.17603CHASSOT_SKIN_WOUND
0.00000 0.00003 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.02445 0.00212 0.00005HUMMEL_BURKITTS_LYMPHOMA_DN
0.01726 0.00000 0.00000KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.16656 0.04003 0.00000KEGG_APOPTOSIS
0.00719 0.16701 0.00288CORUM_NFKB1-NFKB2-REL-RELA-RELB_COMPLEX
0.00000 0.00358 0.00000HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.10553 0.00013 0.00000CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00725 0.00123 0.00000MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.02072 0.02314 0.01874NCI_ATF2_PATHWAY
0.16428 0.01658 0.01122GEORGANTAS_HSC_MARKERS
0.00084 0.16308 0.00038SESTO_RESPONSE_TO_UV_C1
0.03674 0.00000 0.00003CROONQUIST_STROMAL_STIMULATION_UP
0.02804 0.00011 0.05333CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.00152 0.12494 0.09441ZHANG_RESPONSE_TO_CANTHARIDIN_UP
0.11957 0.11533 0.00108DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.02539 0.00147 0.00002HORIUCHI_WTAP_TARGETS_UP
0.09292 0.01387 0.13033NCI_CMYB_PATHWAY
0.13491 0.00000 0.12734RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.04850 0.14474 0.01445BIOCARTA_SODD_PATHWAY
0.09986 0.00000 0.00220CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.09614 0.01019 0.00009KEGG_JAK_STAT_SIGNALING_PATHWAY
0.02725 0.01306 0.01475TSAI_DNAJB4_TARGETS_UP
0.10952 0.16319 0.11465SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.13814 0.00013 0.04300MORI_PRE_BI_LYMPHOCYTE_DN
0.04581 0.00030 0.00000DER_IFN_BETA_RESPONSE_UP
0.05246 0.18332 0.17907GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.00015 0.00144 0.00002DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.07817 0.09165 0.08434NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
0.13255 0.10826 0.08865NCI_FASL__CD95L_SIGNALING
0.02197 0.00013 0.00089AMIT_EGF_RESPONSE_20_HELA
0.01118 0.05198 0.04486GALI_TP53_TARGETS_APOPTOTIC_UP
0.17512 0.01499 0.19250MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.00077 0.00000 0.00000BASSO_CD40_SIGNALING_UP
0.00000 0.00648 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.04862 0.00161 0.00002MARZEC_IL2_SIGNALING_UP
0.09108 0.00871 0.10036BIOCARTA_BLYMPHOCYTE_PATHWAY
0.00318 0.07345 0.02814ZERBINI_RESPONSE_TO_SULINDAC_UP
0.11955 0.12793 0.00002CROMER_TUMORIGENESIS_UP
0.19699 0.00696 0.00001FRIDMAN_SENESCENCE_UP
0.00624 0.02731 0.00219WU_HBX_TARGETS_2_DN
0.00002 0.00029 0.00000MAHADEVAN_RESPONSE_TO_MP470_UP
0.00008 0.00947 0.00016FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.00325 0.01590 0.00058BIOCARTA_TID_PATHWAY
0.06553 0.12888 0.09083AMUNDSON_GAMMA_RADIATION_RESISTANCE
0.05403 0.06898 0.00000ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.04722 0.00004 0.19720BIOCARTA_CTL_PATHWAY
0.00031 0.00000 0.00028KEGG_LEISHMANIA_INFECTION
0.02309 0.02293 0.00099WU_HBX_TARGETS_1_UP
0.00000 0.01709 0.00050CHEN_HOXA5_TARGETS_9HR_UP
0.00289 0.12522 0.02721KANNAN_TP53_TARGETS_UP
0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00937 0.00007 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00002 0.06066 0.08735CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.03178 0.00000 0.11638PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.05612 0.03879 0.00403ENGELMANN_CANCER_PROGENITORS_UP
0.00587 0.00000 0.00011FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.04120 0.09820 0.00079SENESE_HDAC1_TARGETS_UP
0.00459 0.03006 0.01565LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.12773 0.02186 0.02526INGA_TP53_TARGETS
0.00000 0.13365 0.00002KIM_WT1_TARGETS_UP
0.03185 0.01044 0.00000KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.01647 0.00024 0.15379BIOCARTA_GRANULOCYTES_PATHWAY
0.04632 0.00000 0.08966HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00023 0.04510 0.01098ELVIDGE_HYPOXIA_BY_DMOG_UP
0.01652 0.04113 0.05426BIOCARTA_TOLL_PATHWAY
0.00010 0.00511 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.01985 0.00000 0.00008BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.07774 0.01839 0.10933VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
0.07973 0.01712 0.00005RUTELLA_RESPONSE_TO_HGF_UP
0.00000 0.07569 0.00005PRAMOONJAGO_SOX4_TARGETS_UP
0.00002 0.05114 0.02690PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.00221 0.18992 0.08745YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.04742 0.08874 0.11828ELVIDGE_HIF1A_TARGETS_DN
0.19240 0.16432 0.14694LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.07611 0.05826 0.00000ZHU_CMV_24_HR_UP
0.02414 0.00000 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.00038 0.14628 0.00159CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.11465 0.00000 0.00011TENEDINI_MEGAKARYOCYTE_MARKERS
0.00015 0.00000 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.00083 0.01170 0.01124ELVIDGE_HYPOXIA_UP
0.03617 0.18277 0.04532NETPATH_TGFBETA_RECEPTOR_PATHWAY_UP
0.00012 0.00697 0.03327YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.07388 0.00000 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.13041 0.00000 0.13298REACTOME_SIGNALING_IN_IMMUNE_SYSTEM
0.00718 0.00046 0.05748BIOCARTA_LAIR_PATHWAY
0.07711 0.01489 0.00651FRIDMAN_IMMORTALIZATION_DN
0.00005 0.00013 0.00000KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.06558 0.03910 0.00510DAZARD_UV_RESPONSE_CLUSTER_G3
0.03947 0.12062 0.00136XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.10172 0.00001 0.00002OSADA_ASCL1_TARGETS_DN
0.18244 0.02454 0.00000VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.01257 0.00475 0.00000NUYTTEN_EZH2_TARGETS_UP
0.00000 0.00000 0.00000DUTTA_APOPTOSIS_VIA_NFKB
0.16134 0.15485 0.09897SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN
0.00508 0.00169 0.00126TSAI_RESPONSE_TO_IONIZING_RADIATION
0.00157 0.00000 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.03795 0.00007 0.00000DER_IFN_GAMMA_RESPONSE_UP
0.16521 0.00899 0.00010KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.11283 0.03630 0.00004NCI_NFAT_TFPATHWAY
0.00000 0.01092 0.00000ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00085 0.02809 0.00000ONDER_CDH1_TARGETS_3_DN
0.09618 0.00123 0.01985RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.09548 0.07913 0.00332BIOCARTA_ERYTH_PATHWAY
0.04115 0.13021 0.00004HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.02466 0.00000 0.04537NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.01988 0.01021 0.00438NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00017 0.11984 0.02164WINTER_HYPOXIA_METAGENE
0.02400 0.08926 0.00256BROWNE_HCMV_INFECTION_8HR_UP
0.00204 0.13511 0.00012CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_CHUK_KPNA3_NFKB2_NFKBIB_REL_IKBKG__NFKB1_NFKBIE_RELB__NFKBIA_RELA_TNIP2
0.00006 0.00000 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.03788 0.00572 0.00020TAVOR_CEBPA_TARGETS_UP
0.00002 0.00000 0.00000GAURNIER_PSMD4_TARGETS
0.05535 0.03264 0.00020BIOCARTA_HIVNEF_PATHWAY
0.10562 0.04059 0.00001NETPATH_TNF_ALPHA_PATHWAY_UP
0.03341 0.00000 0.09710MARKEY_RB1_CHRONIC_LOF_DN
0.08278 0.00021 0.00044NCI_AMB2_NEUTROPHILS_PATHWAY
0.00257 0.00047 0.00083GESERICK_TERT_TARGETS_DN
0.00289 0.04018 0.00011AMIT_SERUM_RESPONSE_120_MCF10A
0.00034 0.15614 0.00014BROWNE_HCMV_INFECTION_2HR_UP
0.00438 0.17152 0.00001SESTO_RESPONSE_TO_UV_C3
0.03102 0.02731 0.00004REACTOME_DEATH_RECEPTOR_SIGNALLING
0.00000 0.00175 0.00000GEISS_RESPONSE_TO_DSRNA_UP
0.11276 0.00015 0.00000GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.15849 0.00221 0.00653SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.00157 0.09979 0.00000ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.01293 0.00053 0.00000ZHU_CMV_ALL_UP
0.13309 0.16268 0.00002OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.07700 0.00021 0.00010LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.00040 0.00003NAGASHIMA_EGF_SIGNALING_UP
0.00013 0.11440 0.00082AMIT_DELAYED_EARLY_GENES
0.00002 0.02646 0.00000AMIT_EGF_RESPONSE_60_MCF10A
0.02218 0.00000 0.00000KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.00032 0.01772 0.00018NOJIMA_SFRP2_TARGETS_UP
0.00126 0.01170 0.13852CHEN_HOXA5_TARGETS_6HR_UP
0.00008 0.00488 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.07692 0.00021 0.01400SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.01124 0.00697 0.00129AUJLA_IL22_AND_IL17A_SIGNALING
0.11284 0.00006 0.07586LEE_LIVER_CANCER_MYC_TGFA_UP
0.01235 0.03101 0.00001HALMOS_CEBPA_TARGETS_UP
0.05524 0.08566 0.17634NCI_A4B1_PAXINDEP_PATHWAY
0.17667 0.00000 0.00004WALLACE_PROSTATE_CANCER_RACE_UP
0.03235 0.00127 0.00010SAGIV_CD24_TARGETS_DN
0.18732 0.07945 0.19572KEGG_MAPK_SIGNALING_PATHWAY
0.17121 0.00000 0.00002WIELAND_UP_BY_HBV_INFECTION
0.00188 0.05380 0.00015ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.08369 0.15904 0.01179GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.00340 0.18500 0.00317MAHADEVAN_RESPONSE_TO_MP470_DN
0.19498 0.00000 0.00000UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.00027 0.00160 0.00034HARRIS_HYPOXIA
0.00065 0.02531 0.00023NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.04563 0.01570 0.00007KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.01515 0.09168 0.02558KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.10243 0.00005 0.00964NCI_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.00011 0.00003 0.00037SOUCEK_MYC_TARGETS
0.00543 0.17707 0.05842TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.01698 0.16431 0.00384SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.00029 0.00696 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.00031 0.00001 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.00067 0.01097 0.00003DAUER_STAT3_TARGETS_UP
0.14451 0.00000 0.00000DER_IFN_ALPHA_RESPONSE_UP
0.00002 0.05909 0.00523AMIT_EGF_RESPONSE_60_HELA
0.00015 0.02809 0.08973ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.08229 0.00705 0.00016BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.14144 0.07399 0.16529BIOCARTA_GSK3_PATHWAY
0.00079 0.03944 0.00004DAZARD_UV_RESPONSE_CLUSTER_G2
0.00012 0.08348 0.00010NCI_CD40_PATHWAY
0.00030 0.00000 0.00002MCLACHLAN_DENTAL_CARIES_DN
0.17161 0.17342 0.05247GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
0.00874 0.00705 0.00142AMIT_SERUM_RESPONSE_40_MCF10A
0.00000 0.00000 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.03193 0.04213 0.06386WONG_ENDOMETRIAL_CANCER_LATE
0.01261 0.00000 0.00000ZHU_CMV_8_HR_UP
0.00586 0.03251 0.01522BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.05381 0.03146 0.00000BIOCARTA_INFLAM_PATHWAY
0.00000 0.00000 0.00000SANA_TNF_SIGNALING_UP
0.10038 0.00000 0.00000NCI_IL27PATHWAY
0.02541 0.15854 0.00002SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.04723 0.03408 0.00014XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.08527 0.17108 0.17326EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.03557 0.00757 0.00002ONDER_CDH1_TARGETS_2_DN
0.00884 0.07823 0.01395MANALO_HYPOXIA_UP
0.00215 0.00262 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.01185 0.00029 0.03679SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.03411 0.09963 0.00076SENESE_HDAC3_TARGETS_UP
0.12202 0.00000 0.00217KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.00018 0.01646 0.00132XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.00000 0.02814 0.00044UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00546 0.12303 0.02283BIOCARTA_KERATINOCYTE_PATHWAY
0.01346 0.00356 0.05998XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.07974 0.14492 0.00015DASU_IL6_SIGNALING_UP
0.09515 0.01014 0.00743NETPATH_T_CELL_RECEPTOR_PATHWAY_UP
0.00000 0.00001 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.07010 0.05925 0.03224GOUYER_TATI_TARGETS_UP
0.00723 0.10538 0.00000ZUCCHI_METASTASIS_DN
0.05462 0.06405 0.01079NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN